<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Xortx Therapeutics Inc — News on 6ix</title>
<link>https://6ix.com/company/xortx-therapeutics-inc</link>
<description>Latest news and press releases for Xortx Therapeutics Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 11:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/xortx-therapeutics-inc" rel="self" type="application/rss+xml" />
<item>
<title>XORTX Meets Nasdaq Continued Listing Requirements</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-meets-nasdaq-continued-listing-requirements</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-meets-nasdaq-continued-listing-requirements</guid>
<pubDate>Tue, 21 Apr 2026 11:00:00 GMT</pubDate>
<description>CALGARY, Alberta, April 21, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the &#...</description>
</item>
<item>
<title>XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-closing-of-acquisition-of-vectus-kidney-anti-fibrotic-asset</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-closing-of-acquisition-of-vectus-kidney-anti-fibrotic-asset</guid>
<pubDate>Mon, 13 Apr 2026 21:00:00 GMT</pubDate>
<description>&#x2022; VB4-P5 &#x2013; novel new chemical entity with potential to address significant unmet ...</description>
</item>
<item>
<title>XORTX Confirms Effective Date of Share Consolidation</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-confirms-effective-date-of-share-consolidation-3</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-confirms-effective-date-of-share-consolidation-3</guid>
<pubDate>Wed, 01 Apr 2026 17:00:00 GMT</pubDate>
<description>CALGARY, Alberta, April 01, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the &#...</description>
</item>
<item>
<title>XORTX Announces Results of Annual and Special Meeting of Shareholders</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-results-of-annual-and-special-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-results-of-annual-and-special-meeting-of-shareholders</guid>
<pubDate>Thu, 26 Mar 2026 22:00:00 GMT</pubDate>
<description>CALGARY, Alberta, March 26, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the &#...</description>
</item>
<item>
<title>XORTX Announces Change of Effective Date of Share Consolidation</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-change-of-effective-date-of-share-consolidation</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-change-of-effective-date-of-share-consolidation</guid>
<pubDate>Thu, 26 Mar 2026 20:32:43 GMT</pubDate>
<description>CALGARY, Alberta, March 26, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (&#x201C; XORTX &#x2...</description>
</item>
<item>
<title>XORTX Announces Share Consolidation</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-share-consolidation</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-share-consolidation</guid>
<pubDate>Wed, 25 Mar 2026 22:15:00 GMT</pubDate>
<description>CALGARY, Alberta, March 25, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the &#...</description>
</item>
<item>
<title>XORTX Reports that Shareholders Approved the Share Consolidation at the Annual General Meeting</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-reports-that-shareholders-approved-the-share-consolidation-at-the-annual-general-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-reports-that-shareholders-approved-the-share-consolidation-at-the-annual-general-meeting</guid>
<pubDate>Tue, 24 Mar 2026 21:00:00 GMT</pubDate>
<description>CALGARY, Alberta, March 24, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (&#x201C; XORTX &#x2...</description>
</item>
<item>
<title>XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-substitute-director-nominees-for-its-upcoming-annual-and-special-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-substitute-director-nominees-for-its-upcoming-annual-and-special-meeting-of-shareholders</guid>
<pubDate>Wed, 18 Mar 2026 11:00:00 GMT</pubDate>
<description>CALGARY, Alberta, March 18, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the &#...</description>
</item>
<item>
<title>XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote "For" the Share Consolidation</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-reports-that-independent-proxy-advisory-firms-recommend-xortx-shareholders-vote-for-the-share-consolidation-73</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-reports-that-independent-proxy-advisory-firms-recommend-xortx-shareholders-vote-for-the-share-consolidation-73</guid>
<pubDate>Fri, 13 Mar 2026 11:00:00 GMT</pubDate>
<description>Your vote is important &#x2013;&#xA0; Vote well in advance of the proxy voting deadline: March ...</description>
</item>
<item>
<title>XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-filing-and-mailing-of-the-meeting-documents-in-connection-with-the-annual-and-special-meeting-of-shareholders</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-filing-and-mailing-of-the-meeting-documents-in-connection-with-the-annual-and-special-meeting-of-shareholders</guid>
<pubDate>Thu, 05 Mar 2026 12:00:00 GMT</pubDate>
<description>CALGARY, Alberta, March 05, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the &#...</description>
</item>
<item>
<title>XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-provides-update-on-acquisition-of-renal-anti-fibrotic-therapeutic-program-from-vectus-biosystems</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-provides-update-on-acquisition-of-renal-anti-fibrotic-therapeutic-program-from-vectus-biosystems</guid>
<pubDate>Wed, 04 Feb 2026 23:00:00 GMT</pubDate>
<description>CALGARY, Alberta, Feb. 04, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (&#x201C; XORTX &#x20...</description>
</item>
<item>
<title>XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-pioneering-research-on-genome-wide-pathogenic-pathways-in-gout-and-provides-a-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-pioneering-research-on-genome-wide-pathogenic-pathways-in-gout-and-provides-a-corporate-update</guid>
<pubDate>Wed, 31 Dec 2025 23:15:00 GMT</pubDate>
<description>CALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the &#x...</description>
</item>
<item>
<title>XORTX Announces Closing of US$1.1 Million Registered Direct Offering</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-closing-of-usdollar11-million-registered-direct-offering</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-closing-of-usdollar11-million-registered-direct-offering</guid>
<pubDate>Wed, 29 Oct 2025 11:00:00 GMT</pubDate>
<description>CALGARY, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the...</description>
</item>
<item>
<title>XORTX Announces Pricing of US$1.1 Million Registered Direct Offering</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-pricing-of-usdollar11-million-registered-direct-offering</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-pricing-of-usdollar11-million-registered-direct-offering</guid>
<pubDate>Tue, 21 Oct 2025 12:00:00 GMT</pubDate>
<description>CALGARY, Alberta, Oct. 21, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the...</description>
</item>
<item>
<title>XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-issues-correction-notice-and-xortx-announces-180-day-extension-to-regain-compliance-with-nasdaq-minimum-bid-price-deficiency</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-issues-correction-notice-and-xortx-announces-180-day-extension-to-regain-compliance-with-nasdaq-minimum-bid-price-deficiency</guid>
<pubDate>Tue, 21 Oct 2025 00:34:53 GMT</pubDate>
<description>CALGARY, Alberta, Oct. 20, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the...</description>
</item>
<item>
<title>XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-receipt-of-nasdaq-notification-regarding-minimum-bid-price-deficiency</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-receipt-of-nasdaq-notification-regarding-minimum-bid-price-deficiency</guid>
<pubDate>Mon, 20 Oct 2025 22:45:00 GMT</pubDate>
<description>CALGARY, Alberta, Oct. 20, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the...</description>
</item>
<item>
<title>XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-acquisition-of-renal-anti-fibrotic-therapeutic-program-from-vectus-biosystems</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-announces-acquisition-of-renal-anti-fibrotic-therapeutic-program-from-vectus-biosystems</guid>
<pubDate>Fri, 17 Oct 2025 11:00:00 GMT</pubDate>
<description>CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (&#x201C; XORTX &...</description>
</item>
<item>
<title>Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/join-xortx-for-an-exclusive-live-investor-webinar-and-qanda-session-on-september-10</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/join-xortx-for-an-exclusive-live-investor-webinar-and-qanda-session-on-september-10</guid>
<pubDate>Thu, 04 Sep 2025 11:00:00 GMT</pubDate>
<description>CALGARY, Alberta, Sept. 04, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (&#x201C; XORTX ...</description>
</item>
<item>
<title>XORTX Initiates IND Preparation for XORLO(TM) in Gout Program</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-initiates-ind-preparation-for-xorlotm-in-gout-program</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-initiates-ind-preparation-for-xorlotm-in-gout-program</guid>
<pubDate>Wed, 03 Sep 2025 11:00:00 GMT</pubDate>
<description>CALGARY, Alberta, Sept. 03, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (&#x201C; XORTX ...</description>
</item>
<item>
<title>XORTX Initiates IND Preparation for XORLO™ in Gout Program</title>
<link>https://6ix.com/company/xortx-therapeutics-inc/news/xortx-initiates-ind-preparation-for-xorlotm-in-gout-program-1</link>
<guid isPermaLink="true">https://6ix.com/company/xortx-therapeutics-inc/news/xortx-initiates-ind-preparation-for-xorlotm-in-gout-program-1</guid>
<pubDate>Wed, 03 Sep 2025 11:00:00 GMT</pubDate>
<description>Engagement with Allucent supports NDA pathway and advancement of late-stage gout programCALGARY, Alberta, Sept. 03, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, today announced the initiation of Investigational New Drug (“IND”) preparation for its lead program, XRx-026, focused on the tre</description>
</item>
</channel>
</rss>